MedPath

Udwartana followed by Virechana in Dyslipidemia, a Clinical Study

Phase 2
Not yet recruiting
Conditions
Disorder of lipoprotein metabolism, unspecified,
Registration Number
CTRI/2020/03/023890
Lead Sponsor
Dr Reeny Ravina Dias
Brief Summary

Dyslipidemia is the most important atherosclerotic risk factor. Review of population based studies in India shows increasing mean total cholesterol levels. Recent studies reported that high cholesterol is present in 25-30% of urban and 15-20% of rural subjects. In modern science, Statins are the first choice in the treatment of Dyslipidemia, however the need for long term, lifelong therapy with statins is associated with several adverse effects like myopathy, increased risk of acute and chronic renal failure, hypothyroidism and memory loss. Thus, Considering the facts, A comparative clinical study is proposed to compare the efficacy of virechana with and without snehapurva rukshana in the management of dyslipidemia.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria
  • subjects diagnosed with dyslipidemia with any of the serum lipid levels, S. Cholesterol.
  • 200-500mg/dl S. Triglycerides.
  • 150-400mg/dl HDL.
  • <40mg/dl LDL.
  • 130-400mg/dl Subjects fit for Snehapana, Swedana, Udwartana and Virechana VLDL.
Exclusion Criteria
  • Subjects unfit for snehapana, swedana, udwartana and virechana.
  • Subjects with type 1 diabetes, uncontrolled diabetes mellitus, uncontrolled hypertension, cardiovascular diseases Dyslipidemia due to endocrine or renal pathologies Dyslipidemia due to drugs e.g. glucocorticoids etc Pregnant and lactating women.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in Serum Lipid levelsBefore treatment, | After treatment - next day of Virechana, | On follow up - after 15 days of Samsarjana krama
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Sri Sri College of Ayurvedic Science and Research Hospital, Bengaluru

🇮🇳

Bangalore, KARNATAKA, India

Sri Sri College of Ayurvedic Science and Research Hospital, Bengaluru
🇮🇳Bangalore, KARNATAKA, India
Dr Reeny Ravina Dias
Principal investigator
7019176536
reenyravina16@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.